Low molecular weight (LMW) heparin can be used to provide prophylaxis against thromboembolism in obstetrical patients.
Parameters:
(1) type of LMW heparin
(2) body weight in kilograms
(3) risk group
Choice of LMW heparins:
(1) dalteparin
(2) enoxaparin
(3) tinzaparin
|
Body Weight in kg |
Very High Risk? |
Dose Dalteparin |
|
< 50 kg |
No |
2,500 U per day |
|
50 to 90 kg |
No |
5,000 U per day |
|
> 90 kg |
No |
5.000 U q 12 hours |
|
NA |
Yes |
50 to 100 U per kg q 12 hours |
|
Body Weight in kg |
Very High Risk? |
Dose Enoxaparin |
|
< 50 kg |
No |
20 mg per day |
|
50 to 90 kg |
No |
40 mg per day |
|
> 90 kg |
No |
40 mg q 12 hours |
|
NA |
Yes |
0.5 to 1.0 mg per kg q 12 hours |
|
Body Weight in kg |
Very High Risk? |
Dose Tinzaparin |
|
< 50 kg |
No |
3,500 U per day |
|
50 to 90 kg |
No |
4,500 U per day |
|
> 90 kg |
No |
4,500 U q 12 hours |
|
NA |
Yes |
4,500 U q 12 hours |
Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical
